Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential

Amy S Lee1

  • 1Department of Biochemistry and Molecular Biology, University of Southern California Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Room 5308, Los Angeles, California 900899176, USA.

Nature Reviews. Cancer
|March 25, 2014
PubMed

Insights

Glucose-regulated proteins (GRPs) are stress-inducible chaperones with diverse roles beyond heat shock proteins. This review explores their functions in cancer, including signaling, proliferation, and metastasis, and their therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Cancer Biology

Background:

  • Glucose-regulated proteins (GRPs) are stress-inducible chaperones primarily located in the endoplasmic reticulum and mitochondria.
  • Recent research highlights GRPs' distinct functions compared to heat shock proteins, including active translocation and novel roles.

Purpose of the Study:

  • To review the discovery, regulation, and biological functions of GRPs in cancer.
  • To discuss the development of GRP-targeting agents as potential anticancer therapeutics.

Main Methods:

  • Literature review of GRP research.
  • Analysis of GRP roles in cellular processes and cancer development.
  • Evaluation of therapeutic strategies targeting GRPs.

Main Results:

  • GRPs exhibit diverse functions controlling signaling, proliferation, invasion, apoptosis, inflammation, and immunity.
  • Mouse models demonstrate GRP involvement in development, tumorigenesis, metastasis, and angiogenesis.
  • Promising therapeutic agents targeting GRPs are under development for cancer treatment.

Conclusions:

  • GRPs play multifaceted roles in cancer biology, distinct from their chaperone functions.
  • Targeting GRPs represents a promising strategy for novel anticancer therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K